InvestorsHub Logo
Followers 4
Posts 309
Boards Moderated 0
Alias Born 07/09/2018

Re: Snowy_Owl post# 10161

Friday, 01/14/2022 9:34:35 AM

Friday, January 14, 2022 9:34:35 AM

Post# of 10344
Those shareholders "hoping for an ARTH breakthrough" and allies will try to read into this event as auguring a sea change in the fortunes of ARTH as an operating business. Boosters will tell us that something big is coming this way (a la West Side Story).

IMO, this is not the case. First of all, Dr. Fish is accomplished in many areas, but has no hands-on operating experience in any facet of a MedTech firm. He may connections that will open some device evaluation opportunities for ARTH. I would not be swayed by presumptions of his motivations for joining the Board of ARTH.

Secondly, does anyone really think that the lack of a competent advisor or Board member is the fundamental reason for the failure to date of ARTH as an operating company (vs. a penny stock investment play)? Competent wound care consultants are widely available, almost omnipresent. ARTH problems are both more fundamental and broader than the lack of a particular Board member, though an ARTH Board without members being indicted for fraud a step up for ARTH.

In any case, the numbers will tell the story. At some point, this cannot be avoided.